BlossomHill Therapeutics presents at H.C. Wainwright Global Investment Conference - BLSM News | RalliesBlossomHill Therapeutics presents at H.C. Wainwright Global Investment Conference
B
BLSM• Conference presentations scheduled in Boston and New York
- BlossomHill Therapeutics will present at the 8th Annual RAS-Targeted Drug Development Summit on Sept. 10 in Boston.
- Chief Medical Officer Geoff Oxnard is scheduled to deliver the company presentation.
- A separate presentation is set for the H.C. Wainwright 28th Annual Global Investment Conference on Sept. 15 in New York City.
- Founder and CEO Jean Cui is slated to present, with management available for one-on-one investor meetings.
TXXD
•
